Table 4.
Haplotype frequencies in premature CAD patients and healthy controls.
rs11573185 | rs2148911 | rs11573191 | Frequencies | OR (95% CI) | P | ||
---|---|---|---|---|---|---|---|
Total | Control | Premature CAD | |||||
A | G | G | 0.625 | 0.625 | 0.6256 | 1 | — |
C | G | G | 0.151 | 0.165 | 0.1367 | 0.86 (0.69–1.08) | 0.19 |
C | A | G | 0.115 | 0.115 | 0.1153 | 1.12 (0.88–1.44) | 0.36 |
C | G | A | 0.105 | 0.091 | 0.1207 | 1.49 (1.15–1.93) | 0.0023 |
The ORs were adjusted for age, gender, medication, and BMI.
The AGG haplotype was used as reference.